In SCLC, the MEK5–ERK5 axis mediated lipid metabolic reprogramming through regulation of the mevalonate pathway, thereby maintaining tumor cell survival (Cristea et al., 2020). Here, MAP2K5 is linked to small cell lung carcinoma.